JeffreyGeorgeBellMD

PubMed

• 13 citations
  Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.
  Katherine Fuh, James J. Java, John K. Chan, Daniel S. Kapp, Bradley J. Monk, Robert A. Burger, Robert C. Young, William P. McGuire, Maurie Markman, Jeffrey G. Bell, Ro...> ;Gynecologic Oncology. 2019 Aug 1
• 13 citations
  The effect of art therapy on the quality of life in patients with a gynecologic cancer receiving chemotherapy.
  Sara Wiswell, Jeffrey G. Bell, Jennifer McHale, John O. Elliott, Kellie S. Rath, Aine Clements> ;Gynecologic Oncology. 2019 Feb 1
• 17 citations
  Breast Cancer Risk Assessment at the Time of Screening Mammography: Perceptions and Clinical Management Outcomes for Women at High Risk.
  Nichole A. Morman, Lindsey Byrne, Christy L. Collins, Kelly Reynolds, Jeffrey G. Bell> ;Journal of Genetic Counseling. 2017 Jan 26
• 15 citations
  The association between timing of initiation of adjuvant therapy and the survival of early stage ovarian cancer patients – An analysis of NRG Oncology/Gynecologic Onco...
  John K. Chan, James J. Java, Katherine Fuh, Bradley J. Monk, Daniel S. Kapp, Thomas J. Herzog, Jeffrey G. Bell, Robert C. Young> ;Gynecologic Oncology. 2016 Dec 1
• 11 citations
  Outcomes of patients with low-risk endometrial cancer surgically staged without lymphadenectomy based on intra-operative evaluation.
  Jeffrey G. Bell, Diana M. Patterson, Jennifer Klima, Michelle Harvison, Kellie S. Rath, Gary C. Reid> ;Gynecologic Oncology. 2014 Sep 1
• 72 citations
  A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence ris...
  Osama E. Rahma, Ed Ashtar, Malgorzata Czystowska, Marta Szajnik, Eva Wieckowski, Sarah Bernstein, V. E. Herrin, Mortada A. Shams, Seth M. Steinberg, Maria Merino, Will...> ;Cancer Immunology, Immunotherapy. 2012 Mar 1
• 9 citations
  Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: a gynecologic oncology group study.
  John H. Farley, Leia M. Smith, Kathleen M. Darcy, Mark F. Brady, Jeffrey G. Bell, William McGuire, Michael J. Birrer> ;Gynecologic Oncology. 2011 May 1
• 2 citations
  Early detection of ovarian cancer: if only we had a "Pap smear" for this disease.
  Jeffrey G. Bell> ;Cancer. 2011 Oct 1
• 4 citations
  Robotic Radical Prostatectomy at a Teaching Community Hospital: Outcomes and Safety
  Julianna Padavano, Lynn E.T. Shaffer, Elizabeth A. Fannin, John Burgers, Wayne Poll, Eric S. Ward, Kevin Banks, Jeffrey G. Bell> ;JSLS. 2011 Apr 1
• 93 citations
  The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecolo...
  John K. Chan, Chunqiao Tian, Gini F. Fleming, Bradley J. Monk, Thomas J. Herzog, Daniel S. Kapp, Jeffrey G. Bell> ;Gynecologic Oncology. 2010 Mar 1
• 39 citations
  Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study
  John K. Chan, Chunqiao Tian, Deanna Teoh, Bradley J. Monk, Thomas J. Herzog, Daniel S. Kapp, Jeffrey G. Bell> ;Gynecologic Oncology. 2010 Mar 1
• 20 citations
  A Phase II evaluation of weekly topotecan as a single agent second line therapy in persistent or recurrent carcinoma of the cervix: a Gynecologic Oncology Group study.
  James Fiorica, John A. Blessing, Louis V. Puneky, Angeles Alvarez Secord, James S. Hoffman, S. Diane Yamada, Thomas E. Buekers, Jeffrey G. Bell, Jeanne M. Schilder> ;Gynecologic Oncology. 2009 Nov 1
• 37 citations
  Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian...
  Kathleen M. Darcy, William E. Brady, John W. McBroom, Jeffrey G. Bell, Robert C. Young, William McGuire, R. Ilona Linnoila, Denver T. Hendricks, Tomas Bonome, John H. ...> ;Gynecologic Oncology. 2008 Dec 1
• 103 citations
  Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
  John K. Chan, Chunqiao Tian, Bradley J. Monk, Thomas J. Herzog, Daniel S. Kapp, Jeffrey G. Bell, Robert C. Young> ;Cancer. 2008 May 15
• 12 citations
  Randomized trial comparing 3 methods of postoperative analgesia in gynecology patients: patient-controlled intravenous, scheduled intravenous, and scheduled subcutaneous.
  Jeffrey G. Bell, Lynn E.T. Shaffer, Trista Schrickel-Feller> ;American Journal of Obstetrics and Gynecology. 2007 Nov 1
• 120 citations
  Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group ...
  Jeffrey Bell, Mark F Brady, Robert C Young, Janice Lage, Joan L Walker, Katherine Y Look, G Scott Rose, Nick M Spirtos> ;Gynecologic Oncology. 2006 Sep 1
• 10 citations
  Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: A phase I Gynecologic Oncology Group study
  Peter G. Rose, Maurie Markman, Jeffrey Bell, Nancy Fusco> ;Gynecologic Oncology. 2006 Aug 1
• 133 citations
  Randomized Double-Blind Trial of Estrogen Replacement Therapy Versus Placebo in Stage I or II Endometrial Cancer: A Gynecologic Oncology Group Study
  Richard R. Barakat, Brian N. Bundy, Nick M. Spirtos, Jeffrey Bell, Robert S. Mannel> ;Journal of Clinical Oncology. 2006 Feb 1
• 18 citations
  Randomized, double-blind, placebo-controlled trial of vaginal misoprostol for management of early pregnancy failures
  Margit Lister, Lynn E.T. Shaffer, Jeffrey G. Bell, Kathleen Q. Lutter, Karin H. Moorma> ;American Journal of Obstetrics and Gynecology. 2005 Oct 1
• 47 citations
  Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature.
  Ronald D. Hardy, Jeffrey G. Bell, Charles J. Nicely, Gary C. Reid> ;Gynecologic Oncology. 2005 Mar 1
• 34 citations
  An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: ...
  David H. Moore, James Kauderer, Jeffrey Bell, John P. Curtin, Linda Van Le> ;Gynecologic Oncology. 2004 Aug 1
• 4 citations
  The ethics of reporting and disseminating results of clinical research trials.
  Jeffrey G. Bell, Mark F. Brady, Larry J. Copeland> ;Cancer. 2004 Mar 15
• 1086 citations
  A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group...
  Henry M. Keys, James A. Roberts, Virginia L. Brunetto, Richard J. Zaino, Nick M. Spirtos, Jeffrey D. Bloss, Andrew Pearlman, Mitchell Maiman, Jeffrey Bell> ;Gynecologic Oncology. 2004 Mar 1
• 119 citations
  Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
  Laura J. Havrilesky, Kathleen M. Darcy, Hasnah Hamdan, Roger L. Priore, Jorge Leon, Jeffrey G. Bell, Andrew Berchuck> ;Journal of Clinical Oncology. 2003 Oct 15
• 4 citations
  Cisplatin as second-line therapy in ovarian carcinoma treated initially with single-agent paclitaxel: a Gynecologic Oncology Group study.
  J. Tate Thigpen, John A. Blessing, George J. Olt, Samuel S. Lentz, Jeffrey G. Bell> ;Gynecologic Oncology. 2003 Sep 1
• Join now to see all